期刊文献+

冠状动脉介入治疗对急性冠状动脉综合征白细胞介素-37、超敏C反应蛋白、单核细胞及中性粒细胞与淋巴细胞比值的影响 被引量:21

Effect of percutaneous coronary intervention on IL-37, hs-CRP,monocytes, neutrophil and lymphocyte ratio in patients with acute coronary syndrome
下载PDF
导出
摘要 目的探讨经皮冠状动脉介入治疗(PCI)对急性冠状动脉综合征(ACS)患者血浆白细胞介素-37(IL-37)水平、超敏C反应蛋白(hs-CRP)水平、单核细胞计数、中性粒细胞与淋巴细胞比值(NLR)的影响,评估上述炎症指标与ACS类别、Gensini评分、心脏重构和功能关系。方法检测58例ACS患者PCI术前及术后24 h血浆IL-37、hs-CRP水平、单核细胞(M)计数及NLR,常规检测血脂、血浆N端脑钠肽前体(NT-pro BNP)水平、左室舒张末期内径(LVEDD)和左室射血分数(LVEF)。另选同期因胸痛入院且排除冠状动脉粥样硬化性心脏病(冠心病)患者30例为对照组。结果与对照组比较,ACS患者PCI术前血浆hs-CRP水平、M计数及NLR均显著增高,血浆IL-37水平显著降低(P均<0.05);与PCI术前比较,ACS患者术后血浆hs-CRP水平、M计数及NLR增高,血浆IL-37水平降低(P均<0.05)。ACS患者PCI术前血浆IL-37水平与Gensini评分呈负相关;hs-CRP水平、M计数、NLR与Gensini评分、LVEDD和NT-pro BNP水平呈正相关,NLR与LVEF呈负相关。结论 PCI导致体内抗炎/促炎反应失衡加重;PCI术前炎症指标一定程度上反映ACS患者冠状动脉病变严重程度、心室重构和心功能损伤状况。 Objective To investigate the effect of percutaneous coronary intervention(PCI) on anti-inflamation factors IL-37, hs-CRP, monocytes, neutrophil and lymphocyte ratio in patients with acute coronary syndrome and to evaluate the correlation between inflammatory index and Gensini score, cardiac remodeling and function. Methods The levels of plasma IL-37, hs-CRP, periphera monocyte, neutrophil and lymphocyte were detected in 58 patients with ACS 24 hours before and after PCI. Plasma levels of NT-pro BNP, left ventricular end diastolic diameter(LVEDD) and left ventricular ejection fraction(LVEF) were measured as well. Total 30 subjects with chest pain and without coronary heart disease were selected as control group. Results Compared with the control group, the serum hs-CRP levels, peripheral blood monocyte counts and NLR of the ACS group were significantly higher, and the plasma level of IL-37 was lower in the patients of ACS group(P〈0.05). Compared with preoperative state, the peripheral blood monocyte counts, NLR and the serum hs-CRP levels were increased significantly, and the serum levels of IL-37 decreased after PCI were increased(P〈0.05). Preoperative plasma IL-37 levels were negatively correlated with Gensini scores. Preoperative plasma hs-CRP levels, monocyte counts, NLR and were positively related to Gensini scores, LVEDD and NT-pro BNP levels. Preoperative NLR was negatively correlated with LVEF.Conclusions PCI surgery leads further aggravate imbalance of anti-inflammatory /pro-inflammatory response in vivo.The inflammatory indexes such as IL-37 level, hs-CRP, monocyte counts, NLR before PCI reflect coronary lesion severity and ventricular remodeling and heart function in a certain extent in patients with ACS.
出处 《中国现代医学杂志》 CAS 北大核心 2016年第8期44-47,共4页 China Journal of Modern Medicine
关键词 急性冠状动脉综合征 PCI IL-37 单核细胞计数 NLR ACS PCI IL-37 Monocyte counts NLR
  • 相关文献

参考文献13

  • 1Brunetti ND, Correale M, Pellcgrino PL, et al. Early inflammatory cytokine response: a direct comparison between spontaneous coro- nary plaque destabilization vs angioplasty induced[J]. AtheroscIe- rosis. 2014, 236(2): 456-460.
  • 2Boraschi D, Lueehesi D, Hainzl S, et al. IL-37: a new anti-in- flammatory cytokine of the IL-1 family[J]. Eur Cytokine Netw, 2011, 22(3): 127-147.
  • 3Yousif NG, Li J, Yousif F. Expression of IL-37 in mouse pro- tects the myoeardium against isehemie injury via modulation of NF-KB activation[J]. Circulation, 2011, 124(21): A8603.
  • 4无.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2010,38(8):675-690. 被引量:1951
  • 5柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2108
  • 6Sinning C, Lillpopp L, Appelbaum S, et al. Angographic score as asessment improves cardiovascular risk prediction: The clinical value of SYNTAX and Gensini aplication[J]. Clinical Research in Cardiology, 2013, 102(7): 495-503.
  • 7Martin M, Rehani K, Jope RS, et al. Toll-like receptor -mediat- ed cytokine production is differentially regulated by glycogen synthase kinase 3[J]. Nat Immunol, 2005. 6(8): 777-784.
  • 8Ji QW, Zeng QT, Huang Y, et al. Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coro- nary syndrome[J]. Mediators of Inflammation, 2014, (1): 85-87.
  • 9陈少源,贺五一,金健,方红城,谢培益,苏又苏.急性冠状动脉综合征患者白细胞介素-37水平变化的研究[J].中国循环杂志,2014,29(11):871-874. 被引量:10
  • 10Sabatine MS, Morrow DA, Jablonski KA, et al. Prognostic sig- nificance of the centers for disease control/American Heart As- sociation high-sensitivity C-reactive protein cut points for car- diovascular and other outcomes in patients with stable coronary artery disease[J]. Circulation, 2007, 115(12): 1525-1536.

二级参考文献49

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:193
  • 2Collaborative Research Group of Reperfusion Therapy in Acute Myocardial Infarction.重组葡激酶与重组组织型纤溶酶原激活剂治疗急性心肌梗死的随机多中心临床试验[J].中华心血管病杂志,2007,35(8):691-696. 被引量:43
  • 3Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 4Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 5Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 6CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 7Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
  • 8Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
  • 9Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
  • 10Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505.

共引文献3922

同被引文献199

引证文献21

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部